<?xml version="1.0" encoding="UTF-8"?>
<p id="p0025">The carbapenemase producing ability of 
 <italic>K. pnemoniae</italic> was tested against specific antibiotic panel of HX095, HX096, HX066 and HX103 antibiotic discs by disc diffusion method (Clinical &amp; Laboratory Standard Institute Guidelines). The antibiotic discs of aztreonam (AT-30 µg), cefpodoxime (CPD-10 µg), cefpodoxime/Clavulanic acid (CCL-10/5 µg), ceftazidime (CAZ-30 µg), cefotaxime (CTX-30 µg), ceftriaxone (CTR-30 µg) for HX095, cefpodoxime (CPD-10 µg), cefpodoxime/Clavulanic acid (CCL-10/5 µg), ceftazidime (CAZ), ceftazidime/Clavulanic acid (CAC-30/10 µg), cefotaxime (CTX-30 µg) and cefotaxime/Clavulanic acid (CEC-30/10 µg) for HX096, cefepime (CPM-30 µg), cefoperazone (CPZ-75 µg), ceftriaxone (CTR-30 µg), cefoxitin (CX-30 µg), imipenem (IPM-10 µg), ticarcillin/clavulanic acid (TCC-75/10 µg) for HX066 and ciproflaxacin (CIP-5 µg), imipenem (IPM-10 µg), meropenem (MRP-10 µg), ertapenem (ETP-10 µg), cefoperazone/sulbactum (CFS-75/30 µg) piperacillin/tazobactam (PIT-100/10 µg) for HX103 (
 <xref rid="b0225" ref-type="bibr">Subashini et al., 2014</xref>).
</p>
